ACM Global uses state-of-the-art image analytics for quicker turnarounds and more accurate quantitative data.
We employ whole slide imaging technology, as well as tumor cell detection and biomarker quantification software algorithms from Visiopharm.
Leica Biosystems’ Aperio AT2 whole slide scanner expands upon the anatomic pathology testing performed at ACM, while increasing our ability to scale pathology resources for sponsors and CROs conducting global oncology trials. We can send precise electronic slides that are available for remote viewing in less than a minute, and apply computer algorithms to digitized slides to assist pathologists in the identification of areas of interest or in automatically scoring the positivity of various immunohistochemical stains.
Visiopharm’s tumor cell detection and biomarker quantification allows us to give clients objective cell counts. This includes, for example, the exact number of inflammatory cells in a biopsy, or the proportion of tumor cells to normal cells. These objective results are frequently helpful in aiding investigators reach statistical significance in their studies.
A wide range of data management reports are available on request to meet each client’s specific requirements.